- by theguardian
- 07 Oct 2022
The two sides are locked in an increasingly acrimonious legal battle that has swept up some of the biggest names in Silicon Valley and Wall Street.
A five-day trial is scheduled to begin on 17 October in Wilmington, Delaware.
Shares of the San Francisco-based company were down slightly in early Tuesday trading at $41.54.